Episode 235 hosts Kian Moini, an entrepreneur and the owner of 'Q-Tox' based in Sydney, Australia. 

We hosted Kian way back in episode 143, almost two years ago to the day prior to his clinic opening. We re-visit what his goals were for his clinic and learn how he has navigated the challenges of the competitive Sydney aesthetic market. We learn about what worked, what needed tweaking and get an insight into how understanding your CRM data can drive your overall strategy.

In 'The Business of Injecting' episodes we host injectors and clinic owners to discuss all aspects of the business side of their clinic. We analyse their financial struggles and challenges, difficult decisions, friction points, staffing, hiring, firing and other topics relevant for aesthetic business owners.

PATREON:

Join our Patreon for on demand injectable and business education in addition to global networking opportunities with other injectors

SUPPORT THE PODCAST:

Click here if you enjoy listening to IA every week and would like to contribute to supporting the podcast

CHECK OUT OUR SPECIAL OFFERS:

Click here to browse our latest partner offers!

CONTACT INFORMATION:

Contact IA and other important links

Subscribe to IA on Apple Podcasts

Subscribe to IA on Spotify

Follow Dr Jake on Instagram 

Follow David on Instagram

Episode 234 hosts Julie Bass Kaplan (Nurse Practitioner based in California, USA)

This is the 3rd chapter in our mini-series called 'Disasters & Solutions'. Here we look at some of the unusual, difficult or outright disasterous outcomes for patients caused by injectables. We speak to the injectors who managed the case and go through what happened, step by step. We'll learn about what might have been done to prevent the problem and what injectors can do in their own practice to be safer practitioners.

In Chapter 3 we discuss a case concerning a patient who was treated with chin filler. They immediately developed a significant and rare vascular occlusion that affected one side of their tongue. We hear about what was done to salvage the situation and drill down into some fundamental learning points for all injectors.

00:00 Introduction 01:01 Disasters Series Returns 02:48 Case Background Chin Filler 06:04 Consent and Risk Talk 09:04 Technique and Ultrasound Error 18:47 Training Lessons on Ultrasound 20:45 Harlequin Tongue Recognition 23:06 Emergency Protocol and Drills 27:19 Patient Support and Timeline 32:07 Hyaluronidase Dosing and Stock 39:44 Adjuncts Hyperbaric and EO2 43:51 Next Steps Patient and Injector 44:49 Turning Complication Into Paper 46:38 Injector Growth And Confidence 48:20 Patient Care And Communication 58:01 Undiagnosed Occlusions Debate 62:29 Median Canal Anatomy Explained 66:22 Fishing For Red Technique 72:10 VO Mechanisms And Risk Factors 73:38 Emergency Kit And Training 76:37 Refunds Apologies And Support 80:05 Medicolegal Protocols And Notes 85:16 Wrap Up And Where To Learn

ALL IA LINKS & CONTACT INFORMATION

Episode 234 hosts Julie Bass Kaplan, a Nurse Practitioner from California, USA. Better known as Jubilant Julie, she has been injecting since 1999 and is one of the world's most experienced aesthetic injectors.

This is the 3rd chapter in our mini-series called 'Disasters & Solutions'. Here we look at some of the unusual, difficult or outright disasterous outcomes for patients caused by injectables. We speak to the injectors who managed the case and go through what happened, step by step. We'll learn about what might have been done to prevent the problem and what injectors can do in their own practice to be safer practitioners.   

 In Chapter 3 we discuss a case concerning a patient who was treated with chin filler. They immediately developed a significant and rare vascular occlusion that affected one side of their tongue. We hear about what was done to salvage the situation and drill down into some fundamental learning points for all injectors. 

JOIN OUR PATREON:

Join our Patreon for on demand injectable and business education in addition to global networking with other injectors

SUPPORT THE PODCAST:

Click here if you enjoy listening to IA every week and would like to contribute to supporting the podcast

CHECK OUT OUR SPECIAL DISCOUNTS & OFFERS:

Click here to browse our latest partner offers!

CONTACT INFORMATION:

Contact IA and other important links

Subscribe to IA on Apple Podcasts

Subscribe to IA on Spotify

Follow Dr Jake on Instagram 

Follow David on Instagram

Follow Julie on Instagram

Episode 233 hosts Dr Alexander Rivkin (ENT surgeon based in California, USA)

For years injectors have argued bitterly about the pros and cons of theoretical safety manoeuvres performed when injecting fillers. These techniques include aspiration, small or larger movements of the needle tip or even aspiration and moving combined.

We explore the rationale proposed for these procedures and try to understand the merits and limitations of what they might offers us.

00:00 Introduction 01:35 Meet Dr Alexander Rivkin 02:34 From ENT to Aesthetics 04:55 Early Days and Marketing 08:05 Learning to Inject 10:16 Complications and Risk 13:31 Safety Versus Efficacy 16:50 Needle Motion Paper Debate 20:10 Critiquing the Model 27:33 Aspiration Explained 35:02 Bolus Versus Moving Technique 44:54 Teaching Safety to Beginners 47:05 Why Aspiration Feels Safer 47:25 Training Risks and False Confidence 48:15 Patient Comfort and Needle Motion 48:55 Legal Standards and Expert Battles 50:07 What Moving the Needle Means 52:11 Vasospasm and Early Ischemia 56:59 Ultrasound Promise and Pushback 64:15 Dissolving Filler and Integration Myth 67:48 Evidence Gaps and Practical Rules 71:11 Nose Occlusions and Management Steps 76:28 Why Keep Doing Nose Jobs 80:00 Origin of Nonsurgical Rhinoplasty 82:01 Wrap Up and Resources

ALL IA LINKS & CONTACT INFORMATION

Episode 233 hosts Dr Alexander Rivkin, an ENT surgeon from California, USA. 

For years injectors have argued bitterly about the pros and cons of theoretical safety manoeuvres performed when injecting fillers. These techniques include aspiration, small or larger movements of the needle tip or even aspiration and moving combined. 

We explore the rationale proposed for these procedures and try to understand the merits and limitations of what they might offers us. 

PATREON:

Join our Patreon for on demand injectable and business education in addition to global networking opportunities with other injectors

SUPPORT THE PODCAST:

Click here if you enjoy listening to IA every week and would like to contribute to supporting the podcast

CHECK OUT OUR SPECIAL OFFERS:

Click here to browse our latest partner offers!

CONTACT INFORMATION:

Contact IA and other important links

Subscribe to IA on Apple Podcasts

Subscribe to IA on Spotify

Follow Dr Jake on Instagram 

Follow David on Instagram

Episode 232 hosts Dr Pouria Moradi (Plastic Surgeon & Reconstructive Surgeon based in Sydney, Australia)

Pouria recently published his first book entitled 'Normal - A Plastic Surgeon's letter to his daughter about body image'. He first got the idea for the book as he watched his seven year old daughter participating in a swimming carnival. She seemed so proud of herself and completely unaware of how she looked in her cute swimming costume.

But it dawned on him juggling his role as a father and Plastic Surgeon - how long would this innocence would last? Might she soon start asking questions about her body? And if so, what should a father who offers cosmetic surgery every day to other women say?

This is a deep conversation about body image, parenting, ethics and ultimately, we try to understand what is 'normal'?

00:00 Introduction 01:03 Sunday Catch Up 01:26 Meet Dr Pouria Moradi 02:46 Why He Wrote Normal 06:25 Kids and Body Image 09:25 Defining Normal in Surgery 10:39 Parenting and Social Media 12:08 Talking Cosmetic Work at Home 14:35 Reading the Letter 19:11 Ethics and Saying No 25:00 Otoplasty and Medicare Rules 28:56 Book Structure and Resources 31:45 Screening Patients and Red Flags 34:18 Dopamine and Going Bigger 36:37 Reconstructive Roots vs Cosmetic 39:23 Where Surgeons Draw the Line 40:17 Setting Realistic Results 42:08 Aligning Expectations 44:24 3D Imaging Pitfalls 46:06 Depression and BDD 47:57 Social Media Dysphoria 52:59 Surgeon Bias and Referrals 55:43 Patients Versus Clients 61:28 How to Say No 63:24 Transgender Care Basics 67:50 Defending Cosmetic Surgery 71:48 New Cosmetic Guidelines 79:09 Book and Wrap Up

ALL IA LINKS & CONTACT INFORMATION

Episode 232 hosts Dr Pouria Moradi, a Plastic Surgeon & Reconstructive Surgeon from Sydney, Australia.

Pouria recently published his first book entitled 'Normal - A Plastic Surgeon's letter to his daughter about body image'. He first got the idea for the book as he watched his seven year old daughter participating in a swimming carnival. She seemed so proud of herself and completely unaware of how she looked in her cute swimming costume.

But it dawned on him juggling his role as a father and Plastic Surgeon - how long would this innocence would last? Might she soon start asking questions about her body? And if so, what should a father who offers cosmetic surgery every day to other women say?

This is a deep conversation about body image, parenting, ethics and ultimately, we try to understand what is 'normal'? 

CHECK OUT OUR SPECIAL OFFERS:

Click here to browse our latest partner offers!

SUPPORT THE PODCAST:

Click here if you enjoy listening to IA every week and would like to contribute to supporting the podcast

PATREON:

Join our Patreon for on demand injectable and business education in addition to global networking opportunities with other injectors

CONTACT INFORMATION:

Contact IA and other important links

Subscribe to IA on Apple Podcasts

Subscribe to IA on Spotify

Follow Dr Jake on Instagram 

Follow David on Instagram

Episode 231 hosts Ian Carroll (Founder and Managing Director of EnVogue Skin) & Jahan Kalantar (Criminal Lawyer & the principal of 'Executive Law Group')

We discuss the consequences surrounding the alleged actions of a new aesthetic distributor based in Australia.

00:00 Introduction 01:46 Meet our Guests: Ian Carroll & Jahan Kalantar 03:25 Rumors of Unapproved Filler 05:42 How TGA Approval Works 07:38 Risks for Injectors and Clinics 11:31 Legal and Insurance Fallout 17:23 Due Diligence Using ARTG 19:58 Alleged Fake TGA Documents 22:54 What Happens Next 25:30 How This Could Happen 29:56 Bigger Industry Lessons 33:11 Personal Use Import Rules 34:11 Special Access Pathways 36:56 Dodgy DMs and Grey Market 38:07 Counterfeit Risks in Familiar Brands 39:55 Industry Reputation and Regulation 43:36 Verification Tech and QR Codes 45:27 Long Term Complications and Support 47:24 Clinic Crisis Response Playbook 50:29 Legal Triage and Potential Offences 53:39 Market Size and Consumer Danger 55:31 Reporting Suppliers and Staying Cautious 57:32 Key Takeaways and Wrap Up

ALL IA LINKS & CONTACT INFORMATION

Episode 231 hosts Ian Carroll (Founder and Managing Director of EnVogue Skin) and Jahan Kalantar (Criminal Lawyer & the principal of 'Executive Law Group').

We discuss the consequences surrounding the alleged actions of a new aesthetic distributor based in Australia. 

CHECK OUT OUR SPECIAL OFFERS:

Click here to browse our latest partner offers!

SUPPORT THE PODCAST:

Click here if you enjoy listening to IA every week and would like to contribute to supporting the podcast

PATREON:

Join our Patreon for on demand injectable and business education in addition to global networking opportunities with other injectors

CONTACT INFORMATION:

Contact IA and other important links

Subscribe to IA on Apple Podcasts

Subscribe to IA on Spotify

Follow Dr Jake on Instagram 

Follow David on Instagram

Episode 230 hosts Dr John Joseph (Plastic Surgeon from California, USA)

In this mini series 'The Tox Talks', we feature expert injectors who have significant experience in using botulinum toxins. These episodes explore our guests experiences using particular brands, the evolution of their injecting techniques and we get special insights into the subtle nuances of getting the best out of toxins.

In chapter 7 John shares his experiences as a lead clinical study investigator and tells us why he believes we've been doing toxins wrong for the past 35 years. We dangle the possibilities of longer lasting results, less complications, increased patient satisfaction, more time and how to revolutionise the world of toxin treatments.

00:00 Introduction 01:04 Miami Conference Teaser 02:02 Meet Dr John Joseph 02:20 Early Botox Adoption 07:51 Building a Botox Practice 09:00 Why 2.5 mL Became Standard 11:15 Inside Clinical Trials 15:55 On Label vs Off Label 19:20 Eureka on Dose Duration 23:44 Galderma Study and Bias 28:41 How Longer Duration Works 32:28 Measuring Duration and FDA 40:22 Why He Pushed the Science 45:32 Allergan Plateau Findings 46:56 Why Duration Plateaus 47:51 Trial Design and Patient Expectations 50:28 Safety and Field of Effect 52:54 Concentrate to Extend Duration 56:34 Cold Versus Old Data 61:50 90 Units in the Lip 66:06 AccuTox Syringe Prototype 72:04 Running Multiple Dilutions 77:11 Pricing and Practice Economics 81:29 Which Toxin to Stock 83:22 Future Adoption and Consumer Pull 84:54 Resistance and Type E Antidote 90:43 Wrap Up and Next Steps

ALL IA LINKS & CONTACT INFORMATION